Li Liang
Central South University(CN)Chinese PLA General Hospital(CN)The First People's Hospital of Changde(CN)Chengdu University(CN)Chongqing Medical University(CN)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Growth Hormone and Insulin-like Growth Factors, Acute Ischemic Stroke Management, Metabolomics and Mass Spectrometry Studies, Legal and Regulatory Analysis
Most-Cited Works
- → Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack(2008)568 cited
- → Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction(2008)566 cited
- → Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation(2017)226 cited
- → Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa(2001)172 cited
- → Cyanide Trapping of Iminium Ion Reactive Intermediates Followed by Detection and Structure Identification Using Liquid Chromatography−Tandem Mass Spectrometry (LC-MS/MS)(2005)160 cited